BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21926237)

  • 1. Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses.
    Motallebzadeh R; Rehakova S; Conlon TM; Win TS; Callaghan CJ; Goddard M; Bolton EM; Ruddle NH; Bradley JA; Pettigrew GJ
    FASEB J; 2012 Jan; 26(1):51-62. PubMed ID: 21926237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
    Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
    Front Immunol; 2018; 9():3039. PubMed ID: 30740108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germinal Center Alloantibody Responses Mediate Progression of Chronic Allograft Injury.
    Chhabra M; Alsughayyir J; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
    Front Immunol; 2018; 9():3038. PubMed ID: 30728823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of Tertiary Lymphoid Organs in Explanted Rejected Donor Kidneys.
    Xu X; Han Y; Wang Q; Cai M; Qian Y; Wang X; Huang H; Xu L; Xiao L; Shi B
    Immunol Invest; 2016; 45(1):38-51. PubMed ID: 26709668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rejection of tracheal allograft by intrapulmonary lymphoid neogenesis in the absence of secondary lymphoid organs.
    Wagnetz D; Sato M; Hirayama S; Matsuda Y; Juvet SC; Yeung JC; Guan Z; Zhang L; Liu M; Waddell TK; Keshavjee S
    Transplantation; 2012 Jun; 93(12):1212-20. PubMed ID: 23318304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The composition of ectopic lymphoid structures suggests involvement of a local immune response in cardiac allograft vasculopathy.
    Huibers MM; Gareau AJ; Vink A; Kruit R; Feringa H; Beerthuijzen JM; Siera-de Koning E; Peeters T; de Jonge N; de Weger RA; Lee TD
    J Heart Lung Transplant; 2015 May; 34(5):734-45. PubMed ID: 25655346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M1 macrophages act as LTβR-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis.
    Guedj K; Khallou-Laschet J; Clement M; Morvan M; Gaston AT; Fornasa G; Dai J; Gervais-Taurel M; Eberl G; Michel JB; Caligiuri G; Nicoletti A
    Cardiovasc Res; 2014 Mar; 101(3):434-43. PubMed ID: 24272771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production.
    Win TS; Rehakova S; Negus MC; Saeb-Parsy K; Goddard M; Conlon TM; Bolton EM; Bradley JA; Pettigrew GJ
    Circ Heart Fail; 2009 Jul; 2(4):361-9. PubMed ID: 19808360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein.
    Columba-Cabezas S; Griguoli M; Rosicarelli B; Magliozzi R; Ria F; Serafini B; Aloisi F
    J Neuroimmunol; 2006 Oct; 179(1-2):76-86. PubMed ID: 16870269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts.
    Nykänen AI; Sandelin H; Krebs R; Keränen MA; Tuuminen R; Kärpänen T; Wu Y; Pytowski B; Koskinen PK; Ylä-Herttuala S; Alitalo K; Lemström KB
    Circulation; 2010 Mar; 121(12):1413-22. PubMed ID: 20231530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LTBR-pathway in Sjogren's syndrome: CXCL13 levels and B-cell-enriched ectopic lymphoid aggregates in NOD mouse lacrimal glands are dependent on LTBR.
    Fava RA; Browning JL; Gatumu M; Skarstein K; Bolstad AI
    Adv Exp Med Biol; 2011; 691():383-90. PubMed ID: 21153342
    [No Abstract]   [Full Text] [Related]  

  • 13. Artery Tertiary Lymphoid Organs Control Aorta Immunity and Protect against Atherosclerosis via Vascular Smooth Muscle Cell Lymphotoxin β Receptors.
    Hu D; Mohanta SK; Yin C; Peng L; Ma Z; Srikakulapu P; Grassia G; MacRitchie N; Dever G; Gordon P; Burton FL; Ialenti A; Sabir SR; McInnes IB; Brewer JM; Garside P; Weber C; Lehmann T; Teupser D; Habenicht L; Beer M; Grabner R; Maffia P; Weih F; Habenicht AJ
    Immunity; 2015 Jun; 42(6):1100-15. PubMed ID: 26084025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tertiary lymphoid tissues generate effector and memory T cells that lead to allograft rejection.
    Nasr IW; Reel M; Oberbarnscheidt MH; Mounzer RH; Baddoura FK; Ruddle NH; Lakkis FG
    Am J Transplant; 2007 May; 7(5):1071-9. PubMed ID: 17359505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell survival in intragraft tertiary lymphoid organs after rituximab therapy.
    Thaunat O; Patey N; Gautreau C; Lechaton S; Fremeaux-Bacchi V; Dieu-Nosjean MC; Cassuto-Viguier E; Legendre C; Delahousse M; Lang P; Michel JB; Nicoletti A
    Transplantation; 2008 Jun; 85(11):1648-53. PubMed ID: 18551073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 T cell-mediated rejection of cardiac allografts in B cell-deficient mice.
    Nozaki T; Rosenblum JM; Ishii D; Tanabe K; Fairchild RL
    J Immunol; 2008 Oct; 181(8):5257-63. PubMed ID: 18832680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germinal center humoral autoimmunity independently mediates progression of allograft vasculopathy.
    Qureshi MS; Alsughayyir J; Chhabra M; Ali JM; Goddard MJ; Devine CA; Conlon TM; Linterman MA; Motallebzadeh R; Pettigrew GJ
    J Autoimmun; 2019 Mar; 98():44-58. PubMed ID: 30528910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking lymphotoxin beta receptor signalling exacerbates acute DSS-induced intestinal inflammation--opposite functions for surface lymphotoxin expressed by T and B lymphocytes.
    Jungbeck M; Stopfer P; Bataille F; Nedospasov SA; Männel DN; Hehlgans T
    Mol Immunol; 2008 Jan; 45(1):34-41. PubMed ID: 17590442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of allograft survival by inhibitory FcγRIIb signaling.
    Callaghan CJ; Win TS; Motallebzadeh R; Conlon TM; Chhabra M; Harper I; Sivaganesh S; Bolton EM; Bradley JA; Brownlie RJ; Smith KG; Pettigrew GJ
    J Immunol; 2012 Dec; 189(12):5694-702. PubMed ID: 23150718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloimmune-induced intragraft lymphoid neogenesis promotes B-cell tolerance breakdown that accelerates chronic rejection.
    Sicard A; Chen CC; Morelon E; Thaunat O
    Curr Opin Organ Transplant; 2016 Aug; 21(4):368-74. PubMed ID: 27258579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.